Verizon said that it has received U.S. Food and Drug Administration 510(k) clearance for Converged Health Management, a cloud-based, remote patient-monitoring medical device.
This marks the first time Verizon has sought and gained FDA clearance for a healthcare solution, the Company noted in a release.
Verizon said that its new solution, which resides in the company's HIPAA-ready cloud, provides clinicians with access to up- to-date patient data from connected biometric devices so they can more efficiently monitor and manage patients from their home, or when they are on the go.
Health management remains an untapped area with, the Company noted, the potential for enabling clinicians to help patients help themselves through improved awareness of their condition. In addition, access to up-to-date patient health data enables clinicians to deliver more personalized care to patients.
"Verizon is committed to improving the dynamics of the U.S. healthcare system," said Dr. Peter Tippett, chief medical officer and vice president, Verizon Innovation Incubator. "By leveraging our mobile health expertise, HIPAA-ready cloud, 4G LTE wireless network and leading security solutions, Verizon is uniquely positioned to drive innovation in healthcare. Converged Health Management will accelerate focus on care management through mobile technologies as patients increasingly take more responsibility for their health.
"Verizon continues to invest in transformational technologies that address some of the nation's biggest challenges in healthcare," said Tippett.
Verizon's Converged Health Management solution will be commercially available in late 2013.
Verizon's healthcare practice offers a portfolio of managed, IT and consulting services and mobile health solutions.
Verizon Communications Inc. is a provider of broadband and other wireless and wireline communications services to consumer, business, government and wholesale customers.
((Comments on this story may be sent to email@example.com))